Cannabigerol ( CBG ) WHAT IS CBG?
CBG is the acidic precursor of tetrahydrocannabinol ( THC ), cannabidiol ( CBD ) and cannabinol (CBN). This means that CBG is non-psychoactive, but is the building block for the other two more famous cannabinoids. CBG itself has many medicinal benefits without any of the famous high associated with cannabis use.
It is important to differentiate between CBG and THCA which occurs during the process of heating or smoking. This decarboxylation process converts CBGA into THC . CBGA does not have any psychoactive properties, whereas CBDA which is another cannabinoid found in raw cannabis – similar to THCA – has anti-inflammatory, antioxidant and neuroprotective properties. CBGA is cannabis’ natural way to control cell growth in the body. CBG from CBGA enters a metabolic pathway where it becomes CBG. CBG itself cannot get you high but it can reduce intraocular pressure (IOP).
Most CBG found in cannabis is decarboxylated by heat or age into THC . There are only trace amounts of CBG left over once the plant has been dried and cured to make marijuana. This means that there is usually very little CBG found in recreational cannabis since smoking drives off all the terpenes which contain the other cannabinoids such as CBD , CBN and CBC . The vaporizing process preserves these terpenes and CBG can be detected in higher quantities.
The CBG cannabinoid is non-psychoactive but it has been shown to have an effect on bone metabolism, inflammation, antibacterial properties, inhibition of cancerous tumors and lowers IOP. CBG also stimulates the growth of new neurons. CBG does not produce any known side effects or alterations to blood chemistry. CBG can decrease intraocular pressure (IOP) by 25% over 5 days which makes the cannabinoid useful to the treatment of Glaucoma . This means that CBG can lessen the pressure inside the eyeball (similarly to CBD). CBG was tested along with CBN which are both cannabinoids found in raw cannabis before being dried out for smoking. CBG was found to be less efficient than CBN at reducing IOP. CBG is not psychoactive and unlike THC, it also does not form CBN through decarboxylation. CBG and CBN work best together for the treatment of Glaucoma symptoms.
Cannabidiol ( CBD ) WHAT IS CBD?
More about CBG dosage: https://www.neurogan.com/blog/cbg-dosage/
CBD is the second most common cannabinoid found in CBG. CBN and CBDA are also cannabinoids that can be found in CBG. CBN is not psychoactive but it has been proven to have anti-inflammatory, antipsychotic, antibacterial and anticonvulsant effects. CBNA can also reduce intraocular pressure (IOP) which makes CBN helpful for Glaucoma . CBDA is a precursor for cannabidiolic acid ( CBDA ), cannabinolic acid (CBNA), cannabichromenic acid (CBCA), and cannabigerolic acid (CBGA). CBDA as well as CBCA can both inhibit cancerous tumor growths. CBD directly reduces IOP by controlling cellular growth in the body. CBN reduces IOP by controlling CBG metabolic pathways, CBDA activates CBG’s acidic precursor CBGA to begin CBG’s metabolic pathway to create CBD and limit cell growth. CBD is non-psychoactive but it also does not act on CB1 or CB2 receptors which THC works with to get high whereas CBD only attaches itself onto one of the two cannabinoid receptors (CB1).
What is the difference between CBD and CBG?
CBG is CBN’s building block. CBG was tested on rabbits in an experiment to reduce IOP. CBG was applied topically rather than being injected into the eye since CBG cannot get through the blood-brain barrier which would cause psychoactive effects.
CBG was dissolved into propylene glycol and this solution was applied to the eye. CBG displayed a 25% reduction in IOP within 5 days of use. CBN displayed a 15% reduction in IOP over the same time period. CBGA is CBG’s acidic precursor. CBG is non-psychoactive because it cannot get through the blood/brain barrier on its own, but becomes psychoactive if it metabolizes into THC or CBN . CBG reduces intraocular pressure (IOP) by controlling cellular growth in the body with CBGA as its building block rather than THCA which can increase cell growth with CBDA as its building block.
CBD vs CBG vs CBN:
– CBG is psychoactive if it metabolizes into THC or CBN
– CBG reduces IOP by controlling cellular growth in the body with CBGA as its building block rather than THCA which can increase cell growth with CBDA as its building block.
– The ratio of THC: CBD has been found to be a major factor in creating different types of medical cannabis treatments for certain conditions such as glaucoma . THC increases intraocular pressure whereas CBD lowers it so the two have opposite effects on eye pressure .
– CBG reduces IOP by controlling CBG metabolic pathways, CBDA activates CBG’s metabolic pathway to create CBD and limit cell growth. CBN reduces IOP by controlling CBG metabolic pathways, CBDA activates CBG’s metabolic pathway to create CBD and limit cell growth. CBN, CBDA , CBCA, CBGA all reduce cell growth .
– Cannabis that has either high levels of THC or high levels of CBD can be used to effectively treat Glaucoma because THC increases IOP whereas CBD decreases it. The ratio of THCA:CBDA is a major factor in determining CBG’s metabolic pathway to create CBD and reduce cell growth. CBN, CBDA , CBCA, CBGA all reduce cell growth so CBN reduces IOP by controlling CBG metabolic pathways and CBDA activates CBG’s metabolic pathway to create CBD and limit cell growth.
– CBN reduces IOP by controlling CBG metabolic pathways, CBDA activates CBG’s metabolic pathway to create CBD and limit cell growth.